Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment options

GÜR S., Limin M., Hellstrom W. J. G.

EXPERT OPINION ON PHARMACOTHERAPY, cilt.12, sa.6, ss.931-944, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1517/14656566.2011.544252
  • Dergi Adı: EXPERT OPINION ON PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.931-944
  • Anahtar Kelimeler: collagenase, incision and grafting, interferon, Peyronie's disease, tunical lengthening procedures, SHOCK-WAVE THERAPY, TUNICA ALBUGINEA PLICATION, SMALL-INTESTINAL SUBMUCOSA, PENILE CURVATURE, INJECTION THERAPY, INTRALESIONAL VERAPAMIL, NATURAL-HISTORY, FIBROTIC PLAQUE, SINGLE-CENTER, DOUBLE-BLIND
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Peyronie's disease (PD) is a wound-healing disorder of the tunica albuginea of the penis which affects 3-9% of adult males. Clinically, any combination of plaque formation, penile pain, angulation and erectile dysfunction may appear. This condition may progress, stabilize or, uncommonly, regress during the initial acute phase (6 - 18 months).